16-30 of 266
Multidisciplinary Coordination in TK2d Diagnosis and Management
NeuroFrontiersMultidisciplinary Coordination in TK2d Diagnosis and Management
Charles Turck, PharmD, BCPS, BCCCP
Zarazuela Zolkipli-Cunningham, MBChB, MRCP
Oscar H. (Hank) Mayer, MD
Is It Familial or Multifactorial Chylomicronemia Syndrome?
On the Frontlines of Familial Chylomicronemia SyndromeIs It Familial or Multifactorial Chylomicronemia Syndrome?
Steve Jackson, PharmD
Michael D. Shapiro
Evolving epNEC Care: From Default Regimens to Precision-Driven Strategies
Project Oncology®Evolving epNEC Care: From Default Regimens to Precision-Driven Strategies
Alexandria May, PharmD, BCPS
Chandrikha Chandrasekharan, MBBS
Redefining Cancer Care with Functional Precision Medicine
Project Oncology®Redefining Cancer Care with Functional Precision Medicine
Matt Birnholz, MD
Jim Foote, MBA
How KIT D816V Shapes Systemic Mastocytosis Diagnosis and Treatment
Clinician's RoundtableHow KIT D816V Shapes Systemic Mastocytosis Diagnosis and Treatment
Brian P. McDonough, MD, FAAFP
Thanai Pongdee, MD
Improving Diagnostic Accuracy in Systemic Mastocytosis
Clinician's RoundtableImproving Diagnostic Accuracy in Systemic Mastocytosis
Alexandria May, PharmD, BCPS
Tracy George, MD
- advertisement
Breaking Barriers in Familial Chylomicronemia Syndrome
On the Frontlines of Familial Chylomicronemia SyndromeBreaking Barriers in Familial Chylomicronemia Syndrome
Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
Robert Hegele MD, FRCPC
Recognizing TK2d: Key Clinical Signs and Diagnostic Protocols
NeuroFrontiersRecognizing TK2d: Key Clinical Signs and Diagnostic Protocols
Alexandria May, PharmD, BCPS
Kaitlin Batley, MD
Identifying the Respiratory Manifestations of TK2d: The Pulmonologist’s Role
NeuroFrontiersIdentifying the Respiratory Manifestations of TK2d: The Pulmonologist’s Role
Charles Turck, PharmD, BCPS, BCCCP
Bethany Lussier, MD
Advancing Long-Term Outcomes in Systemic Mastocytosis: The Latest Research
Clinician's RoundtableAdvancing Long-Term Outcomes in Systemic Mastocytosis: The Latest Research
Charles Turck, PharmD, BCPS, BCCCP
Anthony Hunter, MD
Urinary and Circulating Tumor DNA in Muscle-Invasive Bladder Cancer: NIAGARA Data
Project Oncology®Urinary and Circulating Tumor DNA in Muscle-Invasive Bladder Cancer: NIAGARA Data
Charles Turck, PharmD, BCPS, BCCCP
Petros Grivas, MD, PhD
ctDNA-Guided Adjuvant Atezolizumab in MIBC: IMvigor011 Insights
Project Oncology®ctDNA-Guided Adjuvant Atezolizumab in MIBC: IMvigor011 Insights
Charles Turck, PharmD, BCPS, BCCCP
Guru P. Sonpavde, MD
- advertisement
Examining the Global Genetic Prevalence of TK2d
NeuroFrontiersExamining the Global Genetic Prevalence of TK2d
Brian P. McDonough, MD, FAAFP
Austin Larson, MD
Unpacking the Genetics of Friedreich’s Ataxia
NeuroFrontiersUnpacking the Genetics of Friedreich’s Ataxia
Arnulf Koeppen, MD
Integrating CMR and Genetics to Improve ATTR-CM Diagnosis
AudioAbstractsIntegrating CMR and Genetics to Improve ATTR-CM Diagnosis
Ryan Quigley